MART-1 (26-35) (human) TFA
MART-1 (26-35) (human) TFA
MART-1 (26-35) (human) TFA, an epitope peptide, is indispensably employed in the realm of biomedical research aimed at immunotherapy advancements. Proficiently directed at melanoma antigens, it exerts an influential impact on inciting the immune system's response against the malignant melanoma cells, thus exhibiting its paramount significance in fostering groundbreaking therapeutic interventions tailored for afflicted melanoma subjects.
Online Inquiry
| CAT# | GR2200 |
| M.F/Formula | C44H75F3N10O16 |
| M.W/Mr. | 1057.12 |
| Appearance | Solid |
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
Write a review
Ask a question
My Review for MART-1 (26-35) (human) TFA
Required fields are marked with *
×
Ask a Question for MART-1 (26-35) (human) TFA
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
